Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2021) will be held from May 29-31, 2021 in Guilin, China. GECT 2021 will cover issues on Biomedicine, Clinical Application of Gene Editing,CRISPR Systems and CRISPR Technologies,Effective Delivery for Genes in Vitro,Gene Knock In and Genomic Screening,Genome Engineering and DNA repair,Single Base Editing, etc. It dedicates to creating a stage for exchanging the latest research results and sharing the advanced research methods.
Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery.
This conference aims to provide an integrated discussion of the latest advances in research and therapeutic development for neurodegenerative diseases.
Remarkable developments in genome editing are revolutionizing medicine and agriculture as large animal genomes can, for the first time, be modified with sophistication and efficiency so far only achievable in the mouse. This technology allows for improvement in livestock production traits, agricultural animal health and welfare, and generation of more refined large animal models for biomedical applications. The summit will bring together reproductive biologists, geneticists, molecular biologists, animal model developers, preclinical and clinical researchers, and representatives of federal research and regulatory agencies.
Biotherapeutics and Vaccines Development Gordon Research Conference Patient-Centric, Modality-Independent, Data-Driven Biotherapeutic and Vaccine Developmen
Biotherapeutics and Vaccines Development Gordon Research Conference Patient-Centric, Modality-Independent, Data-Driven Biotherapeutic and Vaccine Developmen
This is the only international conference that focuses on Vitamin A. In a spirit of cross-disciplinary education, this meeting provides a "home base" for diverse scientists to review the latest concepts and information about retinoid biology and to assess new developments.
Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery.
Currently, technological developments are offering the hope of new therapies for individuals with rare disease at a pace that has the potential for significantly challenging the existing infrastructure for efficient, effective, and equitable delivery.